Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.
Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...
TEMECULA, CALIFORNIA , UNITED STATES, February 10, 2026 /EINPresswire.com/ — Dr. Dayan Goodenowe, author of Breaking Alzheimer’s, will present a formal FDA ...
SYDNEY--(BUSINESS WIRE)--Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical ...
Deep-Transfer-Learning–Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer The first approach led to a ...
Background: Although brain and heart conditions share overlapping risk factors and commonly co-occur, current cardiac and neurologic clinical guidelines are typically produced within specialty silos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results